188 related articles for article (PubMed ID: 6363675)
1. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Nagahama S; Chen YF; Oparil S
J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
[TBL] [Abstract][Full Text] [Related]
2. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
[TBL] [Abstract][Full Text] [Related]
4. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
Nagahama S; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
[TBL] [Abstract][Full Text] [Related]
6. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
[TBL] [Abstract][Full Text] [Related]
7. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
[TBL] [Abstract][Full Text] [Related]
8. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
Chen YF; Jin HK; Paul R; Nagahama S
J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
[TBL] [Abstract][Full Text] [Related]
10. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
Nagahama S; Chen YF; Oparil S
Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
[TBL] [Abstract][Full Text] [Related]
11. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
[TBL] [Abstract][Full Text] [Related]
12. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
Lahlou S; Demenge P
J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
15. Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
Luchsinger A; Grilli M; Velasco M
Am J Ther; 1998 Mar; 5(2):81-8. PubMed ID: 10099042
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive action of bromocriptine in the DOCA-salt hypertensive rat: contribution of spinal dopamine receptors.
Lahlou S; Duarte GP
Fundam Clin Pharmacol; 1998; 12(6):599-606. PubMed ID: 9917201
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
[TBL] [Abstract][Full Text] [Related]
18. Effect of Domperidone on the Bromocriptine-Induced Antihypertensive Action in Hypertensive Patients.
Luchsinger A; Velasco M; Arbona E; Forte P; Gómez J; Sukerman M; Urbina A; Pieretti OH
Am J Ther; 1995 Jun; 2(6):388-394. PubMed ID: 11850682
[TBL] [Abstract][Full Text] [Related]
19. Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Genazzani AR; Petraglia F; Facchinetti F; Golinelli S; Oltramari P; Santoro V; Volpe A
J Clin Endocrinol Metab; 1988 Feb; 66(2):279-82. PubMed ID: 2963016
[TBL] [Abstract][Full Text] [Related]
20. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
